These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8302200)

  • 1. The role of O-antigen in susceptibility of Serratia marcescens to non-immune serum.
    Palomar J; Montilla R; Fusté MC; Viñas M
    Microbios; 1993; 76(308):189-96. PubMed ID: 8302200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide recovery restores susceptibility levels towards beta-lactams in Serratia marcescens.
    Palomar J; Puig M; Montilla R; Lorén JG; Viñas M
    Microbios; 1995; 82(330):21-6. PubMed ID: 7540714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonization requirements of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):204-24. PubMed ID: 6187137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian serum susceptibility of Serratia marcescens: detection of three human serum susceptibility categories.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979; 245(3):301-11. PubMed ID: 44784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of a commercial, intravenously applicable IgG F (ab)2 preparation (Gamma-Venin) to enhance human serum bactericidal activity against Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 249(4):504-11. PubMed ID: 6171949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive protection of NMRI mice against Serratia marcescens: comparative efficacy of commercial human IgG immunoglobulin preparations and rabbit anti-O, -H, -K, -life cell and -protease immune sera.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):480-8. PubMed ID: 6202079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length.
    Grossman N; Leive L
    J Immunol; 1984 Jan; 132(1):376-85. PubMed ID: 6197450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of human serum bactericidal activity by specific IgM antibodies of normal and anti-O immune rabbit sera against pseudo-serum-resistant strains of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):50-66. PubMed ID: 6999780
    [No Abstract]   [Full Text] [Related]  

  • 10. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):495-511. PubMed ID: 44945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes.
    Simberkoff MS; Ricupero I; Rahal JJ
    J Lab Clin Med; 1976 Feb; 87(2):206-17. PubMed ID: 1107450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotyping of Serratia marcescens: confirmation of five recently described new O-antigens and characterization of an additional O-antigen.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):307-11. PubMed ID: 7029967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of surface polysaccharide in determining the resistance of Serratia marcescens to serum killing.
    Jessop HL; Lambert PA
    J Gen Microbiol; 1986 Sep; 132(9):2505-14. PubMed ID: 3540205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lipopolysaccharide in complement-killing of Aeromonas hydrophila strains of serotype O:34.
    Merino S; Camprubí S; Tomás JM
    J Gen Microbiol; 1991 Jul; 137(7):1583-90. PubMed ID: 1955853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic study of "Serratia marcescens" isolated in France.II.--Characterization of O antigens and description of 5 new O factors, occurrence of serotypes and labelling of new H factors (author's transl)].
    Le Minor S; Pigache F
    Ann Microbiol (Paris); 1978 Oct; 129 B(3):407-23. PubMed ID: 85425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New O (O21) and H (H21-H25) antigenic factors of "Serratia marcescens": subdivision of O factors 5, 10 and 16 (author's transl)].
    Le Minor S; Sauvageot-Pigache F
    Ann Microbiol (Paris); 1981; 132(3):239-52. PubMed ID: 6170245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological relationships of the O antigens of Klebsiella pneumoniae O5, Escherichia coli O8 and a new O serotype of Serratia marcescens.
    Aucken HM; Pitt TL
    FEMS Microbiol Lett; 1991 May; 64(1):93-7. PubMed ID: 1713181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human serum bactericidal activity against Serratia marcescens: failure of human, "natural," specific anti-O IgG antibodies to enhance serum bactericidal activity.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):84-91. PubMed ID: 7032154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological evaluation of Serratia marcescens clinical isolates in a general hospital during the past three years: appearance of O-antigens O2 and O14].
    Marumo K; Nakamura Y; Sakurai C
    Rinsho Byori; 1998 Jul; 46(7):728-33. PubMed ID: 9721543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serratia marcescens adherence: the effect of O-antigen presence.
    Palomar J; Leranoz AM; Viñas M
    Microbios; 1995; 81(327):107-13. PubMed ID: 7476554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.